The OPPA, a district branch of the American Psychiatric Association, is a statewide medical specialty organization whose more than 1,000 physician members specialize in the diagnosis, treatment and prevention of mental illnesses, including substance use disorders.
The OPPA planning committee for the 2017 Annual Psychiatric Update has worked hard over the past several months to plan an outstanding program with nationally renowned speakers. The theme of the program, Mental Illness - Helping Ourselves, Our colleagues and Our Patients, addresses some serious and important topics facing many physicians today. Read More
The State Medical Board of Ohio recently emailed 12,000 (one-third of physicians licensed in Ohio) saying that according to an Ohio Automated Rx Reporting System (OARRS) audit report conducted by the State of Ohio Board of Pharmacy (SOBP) they are not compliant with requirements related to prescribing opioids. The e-mail threatened possible action against these physicians' licenses and/or a $20K fine for unspecified viloations to required utilization of OARRS. Read More
As reported in the Health Affairs article: MACRA Final Rule: CMS Strikes a Balance; Will Docs Hang On?, the Centers for Medicare and Medicaid Services (CMS) released the Final Rule implementing the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Read More
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) changes the way psychiatrists and other physicians working with Medicare patients will be paid. Some reporting requirements begin as early as January 1, 2017. Read More
The United States Drug Enforcement Administration (DEA) has announced it will reduce the amount of almost every Schedule II opiate and opioid medication that may be manufactured in the United States in 2017 by 25 percent or more, according to a Final Order being published in the Federal Register. Read More
October 27, 2016
November 14, 2016